logo
PERFLUOROCARBONS IN TRANSFUSION MEDICINE
HEMOGLOBIN SOLUTION - WHERE ARE WE NOW?
Impact of Red Cell Substitutes on Transfusion Services
ORGANISATION OF BLOOD SERVICES
RECOMBINANT PRODUCTS FOR THE TREATMENT OF HAEMOPHILIA
Recombinant Plasma Proteins from Transgenic Animals
SUBSTITUTES FOR PLATELET TRANSFUSIONS
OVERVIEW OF CLINICAL EFFECTIVENESS AND DONOR CARE OUTCOMES
DEVELOPMENT OF CARE PATHWAYS FOR THE NATIONAL BLOOD SERVICE
WHAT IS CLINICAL AUDIT? WHAT IS QUALITY AUDIT? HOW DO THEY DIFFER?
ROLE OF TRAINING TO FACILITATE IMPLEMENTATION OF OUTCOMES
YEAR 2000 COMPLIANCE WITHIN THE SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE (SNBTS)
ELECTRONIC COMMUNICATIONS BETWEEN BLOOD CENTRES AND BLOOD BANKS.
COMPUTER CROSSMATCH GUIDELINES.
CODE 128
SERIOUS HAZARDS OF TRANSFUSION (SHOT) SCHEME: THE FIRST ANNUAL REPORT 1996-97
ERRORS IN THE LABELLING OF BLOOD TRANSFUSION REQUEST FORMS AND SPECIMEN TUBES: FINDINGS OF A SINGLE-CENTRE STUDY
A RETROSPECTIVE STUDY ON RED CELL TRANSFUSION IN PRIMARY TOTAL KNEE REPLACEMENT
ADDRESSOGRAPH STICKERS: AN IMPORTANT CAUSE OF LABELLING ERRORS IN BLOOD TRANSFUSION MEDICINE
ARE DONATIONS FROM REPEAT DONORS SAFER THAN DONATIONS FROM NEW DONORS?
HUMAN RECOMBINANT SCFVS SPECIFIC FOR THE HYPERVARIABLE REGION 1 OF HCV FROM IMMUNE PHAGE DISPLAY LIBRARIES.
Large scale HCV RNA screening in first-time blood donors: the first step towards genomic screening of blood donations.
PREVALENCE OF HIV-1 AMONGST ANTE-NATAL WOMEN IN UGANDA SHOWS A DECLINE.
PRODUCTION AND CHARACTERISATION OF MONOCLONAL ANTI-IDIOTOPIC ANTIBODIES TO BRAD-5 MONOCLONAL ANTI-RhD ANTIBODY
AN EVALUATION OF THE DIAMED FMH KIT COMBINED WITH FLOW CYTOMETRY FOR THE ESTIMATION OF FOETOMATERNAL HAEMORRHAGE (FMH)
THE EXPRESSION OF MHC I AND II ANTIGENS IN BANKED HUMAN SKIN.
THE FREQUENCY OF A2 AND B SPECIFIC NUCLEOTIDES ON THE O1 ALLELE OF AFROCARIBBEAN DONORS AS DETERMINED BY PCR-SSP.
Plasma fractionation: present and future challenges and opportunities
NIBSC AND THE UKBTS - FORWARD TOGETHER
VIRAL GENOME AMPLIFICATION TESTING: RATIONALE, PROJECTED YIELD, AND STRATEGIES
Prions and the immune system
A SAFE BLOOD SUPPLY - SAFETY VERSUS COST
VIRUS INACTIVATION OF BLOOD COMPONENTS
LEUKODEPLETION
DIRECT DETECTION OF BACTERIA IN BLOOD COMPONENTS USING BACTERIAL RIBOSOMAL RNA DIRECTED PROBES COUPLED TO ELECTROCHEMILUMINESCENCE
ROLE OF THE BBTS IN EDUCATION AND TRAINING
FUTURE STATE REGISTRATION AND MAINTAINING COMPETENCE
TRANSFUSION SCIENCE & TRAINING IN THE NBS
FUTURE TRANSFUSION SCIENCE TRAINING REQUIREMENTS IN HOSPITALS
THE ABO SYSTEM - SOME RECENT ADVANCES
THE RH SYSTEM - SOME RECENT ADVANCES
Structure and function of red cell membrane proteins
THE 1990s IN CELLULAR IMMUNOTHERAPY: FROM DENDRITIC CELLS TO TUMOR-SPECIFIC T CELLS
BIOLOGY AND THERAPEUTIC POTENTIAL OF DENDRITIC CELLS (DC)
Genetically Modified Cellular Immunotherapy
DISAPPEARANCE OF THE CROMER ANTIBODY ANTI-WESb DURING PREGNANCY
THE MNS BLOOD GROUP ANTIGENS Osa (MNS38) AND Nya (MNS18) RESULT FROM GLYCOPHORIN A AMINO ACID SUBSTITUTIONS
FUNCTIONAL CELL SURFACE EXPRESSION OF BAND 3 (AE1) IN K562 ERYTHROLEUKEMIA CELLS ENHANCES THE CELL SURFACE EXPRESSION OF RH ANTIGENS.
PARTIAL D RED CELLS REQUIRED FOR RAPID DETERMINATION OF MONOCLONAL ANTI-D EPITOPE SPECIFICITY IN THE 36 EPITOPE MODEL
ERYTHROCYTE BAND 3 MUTATION Pro561→Ser GIVES RISE TO THE BOW ANTIGEN AND Pro566→Ala TO A NOVEL ANTIGEN KREP
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA IN THE LONDON AND SOUTH EAST ZONE OF ENGLAND
APPROACH TO FRACTIONATION OF NON-UK PLASMA
CURRENT PRACTICE FOR REPLACEMENT OF CLOTTING FACTORS IN RUPTURED ABDOMINAL AORTIC ANEURYSM
QUANTITATION OF WBC SUBSETS IN LEUKOREDUCED RED BLOOD CELLS
RECOMBINANT IgG LACKING FcγRI BINDING AND COMPLEMENT/CHEMILUMINESCENCE ACTIVATION.
IMPROVED BLOOD SAFETY FOLLOWING A FATAL TRANSMISSION OF MALARIA
MEETING THE NEEDS OF ASIAN BLOOD DONORS
INACTIVATION OF VIRUSES IN COAGULATION FACTOR CONCENTRATES BY DRY-HEAT TREATMENT.
THE EFFECTS OF FREEZE-DRYING ON THE MECHANICAL PROPERTIES OF HUMAN CORTICAL BONE.
ESTABLISHING THE MAJOR SOURCES OF CADAVERIC TISSUE CONTAMINATION DURING RETRIEVAL
USE OF VNTR ANALYSIS TO DETERMINE THE CHIMERIC STATUS OF LONG TERM SURVIVORS OF HLA MISMATCHED BONE MARROW TRANSPLANTATION
FURTHER INVESTIGATION OF THE OBSERVED LINK BETWEEN HUMAN CYTOMEGALOVIRUS INFECTION AND SYSTEMIC LUPUS ERYTHEMATOSUS
DETECTION OF HLA-HFE MUTATIONS BY PCR-SSP
OVERVIEW: IMMUNOMODULATION BY TRANSFUSION
Immunological Aspects of Transfusion
CLINICAL EFFECTS OF IMMUNOLOGICAL ASPECTS OF BLOOD TRANSFUSION
AN OVERVIEW OF EUROPEAN BLOOD BANKING PRACTICES
IMPLEMENTATION OF THE EC IN VITRO DIAGNOSTICS MEDICAL DEVICE DIRECTIVE - IMPLICATIONS FOR MANUFACTURERS AND USERS OF BLOOD GROUPING REAGENTS
BEDSIDE TESTING
THE BLOOD BANK IN DENMARK
COMPLEX RELATION BETWEEN AMOUNT OF CELL BOUND IgG AND HAEMOLYSIS
IgG2 ANTIBODIES AND AIHA
PCH ANTIBODY IS NOT ALWAYS ANTI-P
OVERVIEW OF CURRENT METHODS FOR QUANTITATING RED CELL BOUND IMMUNOPROTEIN
IgA CLASS RED CELL AUTOANTIBODIES: RELATIONSHIP BETWEEN AMOUNT OF BOUND IMMUNOGLOBULIN AND RED CELL DESTRUCTION
A FLUCTUATING ANTI-D LEVEL IN A TWIN PREGNANCY WITH UNUSUAL Rh GENOTYPES - CASE REPORT
MAPPING OF EPITOPES RECOGNISED BY Fyb - SPECIFIC BLOOD GROUP ANTIBODIES AND GENETIC ANALYSIS OF Fyb - WEAK INDIVIDUALS
RH MOSAICISM IN MYELOFIBROSIS
A RAPID DIFFERENTIAL ABSORPTION METHOD TO DETECT RED CELL ALLOANTIBODIES IN THE PRESENCE OF AUTOANTIBODIES
THE TECAN GENESIS ROBOTIC HANDLER AND ZENYX IMAGE ANALYSIS READER FOR ROUTINE ANTENATAL ANTIBODY SCREENING
MEASURING RED CELL CLEARANCE BY FLOW CYTOMETRY.
ANALYSIS OF ANTI-D FABS BY FLOW CYTOMETRY.
ANTI-D QUANTITATION BY FLOW CYTOMETRY: A COMPARISON OF FIVE METHODS
QUANTITATION OF FETO-MATERNAL HAEMORRHAGE BY FLOW CYTOMETRY USING Hb:F STAINING
CAN FETAL CELLS WITH WEAK RhD BE DETECTED IN THE MATERNAL CIRCULATION BY FLOW CYTOMETRY?
FINDING BLOOD OF RARE RED CELL PHENOTYPES
VALIDATION OF API RFA-300 ANALYSERS FOR ANTIBODY QUANTITATION
A COMPARISON OF THE ACCURACY OF ESTIMATING FMH BY KLEIHAUER AND FLOW CYTOMETRY.
CHARACTERISATION OF CLASS, SUBCLASS AND SPECIFICITY OF ANTI-D ANTIBODIES PRODUCED AS A RESULT OF PREGNANCY AND PLANNED IMMUNISATION.
AN RhD NEGATIVE FEMALE TRANSPLANTED WITH LUNG LOBES FROM TWO RhD/ABO INCOMPATIBLE DONORS
AN INDIVIDUAL OF PHENOTYPE GP. JL WITH ANTI-Wrb/EnaFR: A CASE STUDY
A COMPLEX SEROLOGICAL INVESTIGATION INVOLVING ANTIBODIES TO TWO HIGH FREQUENCY ANTIGENS
FMH QUANTITATION BY FLOW CYTOMETRY - USE OF PHYCOERYTHRIN CONJUGATED ANTI-GLYCOPHORIN A TO IMPROVE ACCURACY
DETECTION OF WEAK D AND DVI RED CELLS IN D NEGATIVE MIXTURES BY FLOW CYTOMETRY-IMPLICATIONS FOR FMH QUANTITATION
AN ALTERNATIVE APPROACH TO ELECTRONIC CROSSMATCHING
IDENTIFICATION OF ALLO- & AUTO-ANTIBODY SPECIFICITIES FOLLOWING AUTOANTIBODY ABSORPTION USING ZZAP TREATED CELLS.
ANTENATAL SCREENING OF 'HIGH RISK' PATIENTS AT THE WELSH BLOOD SERVICE.
REDUCTION OF k EXPRESSION IN A Kp(a+b−) ANTIBODY IDENTIFICATION PANEL CELL
THE USE OF POLYETHYLENE GLYCOL FOR THE ADSORPTION OF WARM AUTO-ANTIBODIES
THE EXPRESSION OF HUMAN BLOOD GROUP-ACTIVE PROTEINS DURING ERYTHROPOIESIS AS REVEALED BY CULTURE OF CORD BLOOD PROGENITORS IN VITRO
CASE REPORT: ANTI-JKa, OF DEMONSTRATED CLINICAL SIGNIFICANCE, DETECTABLE ONLY BY A NONSTANDARD TECHNIQUE
CAN ANTIBODIES TO SERUM IgG GROUPS [Gm ANTIBODIES] BE IGNORED IN TRANSFUSION REACTIONS?
HOW WELL ARE BLOOD SAMPLES LABELLED AND REQUEST FORMS COMPLETED? REPORT OF AN INTERNAL AUDIT
VARIABLITY IN EXPRESSION OF THE FY GENE
MOLECULAR BASIS AND CLINICAL SIGNIFICANCE OF DHMI
PRION PROTEIN EXPRESSION ON PERIPHERAL BLOOD LEUCOCYTES DETERMINED BY FLOW CYTOMETRY.
MULTICENTRE INTERNATIONAL TRIAL OF AN ELISA KIT FOR SIMULTANEOUS PLATELET HPA-1 PHENOTYPING AND ANTI-HPA1a ANTIBODY TESTING.
REMOVAL OF ANTI-HPA1a ANTIBODY FROM PLASMA USING GPIIb/IIIa-IMMOBILISED BEADS: POTENTIAL CLINICAL APPLICATION.
EPITOPE MAPPING OF HLA CLASS I REVISITED
WHITE CELL ANTIBODIES IN FEBRILE REACTIONS - DO NON-CYTOTOXIC/NON-HLA ANTIBODIES OCCUR?
UNEXPECTEDLY BENIGN OUTCOME OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT) DUE TO ANTI HPA 3a
DETECTION OF PAIg IN PATIENTS WITH AITP USING THE PIFT AND MAIPA ASSAY.
GENOTYPING OF AMNIOTIC FLUID FOR HUMAN PLATELET ANTIGENS (HPA) IN FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA (FMAITP)
ACUTE LUNG INJURY FOLLOWING TRANSFUSION OF RED CELLS IN ADDITIVE SOLUTION: A CASE REPORT
VALUE OF PRE-HARVEST PERIPHERAL BLOOD CD34 COUNTS IN PREDICTING STEM CELL HARVEST YIELDS.
POST-TRANSFUSION PURPURA (PTP) DUE TO ANTI HPA 2b IN A PATIENT WITH THALASSAEMIA MAJOR
ACCELERATED HAEMOLYSIS AFTER TRANSFUSION IN MANTLE CELL LYMPHOMA
ANTI-Rh(D) PROPHYLAXIS IN A PATIENT WITH ANTI-IgA ANTIBODIES
AUDIT OF USAGE OF 20% ALBUMIN
AUDIT OF ANTI-D ADMINISTRATION ACCORDING TO CURRENT GUIDELINES
CONSENT - THE LEGAL ISSUES
HIP FRACTURE AND TRANSFUSION TRIAL (HATT)
MASSIVE FETO MATERNAL HAEMORRHAGE: CASE REPORT
PROVISION OF HLA MATCHED PLATELETS FOR HIGHLY IMMUNISED PATIENTS: A CASE STUDY
THE EFFECTIVE USE OF BLOOD PROGRAMME
AUDIT OF CRYOPRECIPITATE USAGE IN ABERDEEN ROYAL HOSPITALS
THE OUTCOME OF PREGNANCY IN KELL ALLOIMMUNISATION
AUDIT ON CLOTS IN THE BLEED LINE
AUDIT ON INTENSIVELY TRANSFUSED NEONATES
THE STRANGE CASE OF THE LOST LEG
CRYOPRECIPITATE FROM (METHYLENE BLUE+LIGHT) VIRUS-INACTIVATED PLASMA
DO LEUCOCYTE FILTERS CAUSE LYSIS OF WHITE CELLS, AND DO THEY REMOVE ALL LEUCOCYTE SUBSETS?
IN VITRO MEGAKARYOPOIESIS: STUDIES USING VARIOUS COMBINATIONS OF THROMBOPOIETIN (Tpo), IL3, IL11 AND STEM CELL FACTOR (SCF)
APPLICATION OF A TIME-RESOLVED FLUORO-IMMUNOASSAY FOR THE CELLULAR FORM OF PRION PROTEIN.
EVALUATION OF THE PALL AUTOSTOP® LEUCODEPLETION FILTER, WITH INTEGRAL CLX® HP STORAGE BAG, FOR PREPARATION OF LEUCODEPLETED POOLED PLATELETS DERIVED FROM BUFFY COATS FOR 7 DAYS STORAGE.
QUANTITATION OF WBC SUBSETS IN LEUKOREDUCED PLATELET CONCENTRATES
ANTI-Rh D ACTIVITY OF COMMERCIAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) PREPARATIONS
ANALYSIS OF CARBOHYDRATE COMPOSITION OF RECOMBINANT HUMAN ANTI-VARICELLA ZOSTER ANTIBODIES PRODUCED IN NS0 CELLS.
THE NATIONAL HCV REGISTER
HemoCue Screening of Hb Concentration For Blood Donors Needs Careful Monitoring and Control
HEMOCUE HAEMOGLOBIN ESTIMATION ON VENOUS BLOOD SAMPLES OF DONORS WHO FAIL THE COPPER SULPHATE SCREENING TESTS LEADS TO THE GAIN OF MANY UNITS WHICH WOULD OTHER WISE HAVE BEEN LOST.
ACCURACY OF HEMOCUE VENOUS BLOOD HAEMOGLOBIN ESTIMATIONS AT BLOOD DONOR SESSIONS
APHERESIS RECRUITMENT: A JOB FOR ALL STAFF
THAT SINKING FEELING.
WHY SOME DONORS ARE "ECONOMIC WITH THE TRUTH" II
"MUCH ADO ABOUT NOTHING": FALSE POSITIVE PCR RESULTS FOR TWO ANTI-HCV RIBA INDETERMINATE DONORS
A case of Genetic Haemochromatosis in a healthy blood donor
NATIONAL BLOOD STOCKS PROJECT
HC(84)7 - HOSPITAL BLOOD STOCK DATA
INVESTIGATION AND SELECTION OF HLA IDENTICAL SIBLING DONORS FOR PERIPHERAL BLOOD PROGENITOR CELL ALLOGENEIC TRANSPLANTATION
AN AUDIT OF TOXICITIES RELATED TO PERIPHERAL BLOOD PROGENITOR CELL COLLECTIONS IN PATIENTS AND ALLOGENEIC SIBLING DONORS
A ONE YEAR STUDY OF SIBLINGS EXPERIENCES OF DONATION OF PERIPHERAL BLOOD PROGENITOR CELLS
COBE SPECTRA LRS TURBO SYSTEM ONE ARE TECHNIQUE
MALARIAL ANTIBODY TESTING: ONE YEAR EXPERIENCE
HEPATITIS C MINI-POOL PCR TESTING: IN SCOTLAND AND NORTHERN IRELAND
EVALUATION OF AN AUTOMATED VIROLOGY TESTING SYSTEM.
COMPARISON OF THE PERFORMANCE OF PRISM HCV WITH ANTI-HCV 3.0 FOR SCREENING BLOOD DONATIONS AND TRANSFUSION RECIPIENTS FOR HEPATITIS C VIRUS (HCV).
IN VITRO DIFFERENTIATION OF DENDRITIC CELLS FROM PERIPHERAL BLOOD MONOCYTES
SPECIES ORIGIN OF LIVER: AN UNUSUAL REQUEST
IDIOTOPIC ANALYSIS OF RhD IMMUNE SERUM
FLOW CYTOMETRIC QUANTITATION OF MONOCYTE PHAGOCYTOSIS OF SENSITISED RED BLOOD CELLS USING PKH-26 DYE
SEVERE IMMUNE HAEMOLYSIS AFTER ABO MISMATCHED RENAL TRANSPLANTATION
HARVESTING OF HAEMATOPOIETIC STEM CELLS IN UMBILICAL CORD BLOOD
THE WELSH ASSESSMENT OF SEROLOGICAL PROFICIENCY SCHEME (WASPS)
A COMPARISON BETWEEN ERRORS DOCUMENTED IN NEQAS(BGS) EXERCISES AND THE SHOT ANNUAL REPORT 1996/1997.
COMPARISON OF ANTIBODY FREQUENCIES BETWEEN SHOT REPORT AND UK NEQAS(BGS) EXERCISES.
A Review of the Use of Platelet Coolant Packs.
EFFECTIVE REAGENT PROVISION: QUALITY, COST AND CUSTOMER SUPPORT